Home/Filings/4/0001479290-20-000015
4//SEC Filing

Joshi Abhay 4

Accession 0001479290-20-000015

CIK 0001479290other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 8:16 PM ET

Size

7.1 KB

Accession

0001479290-20-000015

Insider Transaction Report

Form 4
Period: 2020-01-23
Joshi Abhay
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2020-01-23+25,000106,511 total
  • Award

    Employee Stock Option (Right to Buy)

    2020-01-23+146,500146,500 total
    Exercise: $22.32Exp: 2030-01-22Common Stock (146,500 underlying)
Footnotes (2)
  • [F1]The shares subject to the Restricted Stock Award shall vest in three (3) equal annual installments beginning from February 15, 2020, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan(the "Plan")) on each vesting date.
  • [F2]The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 23, 2020, subject to Dr. Joshi's Continuous Service (as defined in the Plan) on each vesting date.

Issuer

Revance Therapeutics, Inc.

CIK 0001479290

Entity typeother

Related Parties

1
  • filerCIK 0001359089

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 8:16 PM ET
Size
7.1 KB